— Know what they know.
Not Investment Advice

CDNA NASDAQ

CareDx, Inc
1W: +5.3% 1M: +4.6% 3M: +14.7% YTD: +12.7% 1Y: +21.6% 3Y: +177.6% 5Y: -67.3%
$21.63
+0.06 (+0.28%)
 
Weekly Expected Move ±5.9%
$18 $19 $20 $21 $22
NASDAQ · Healthcare · Medical - Diagnostics & Research · Alpha Radar Buy · Power 61 · $1.1B mcap · 49M float · 1.44% daily turnover · Short 44% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
51.8 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -7.2%  ·  5Y Avg: -41.6%
Cost Advantage
63
Intangibles
81
Switching Cost
33
Network Effect
43
Scale
28
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CDNA shows a Weak competitive edge (51.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. Negative ROIC of -7.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$28
Low
$28
Avg Target
$28
High
Based on 1 analyst since Apr 28, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 3Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$27.00
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-29 BTIG $26 $28 +2 +27.8% $21.91
2026-02-25 BTIG Sung Ji Nam $35 $26 -9 +40.8% $18.46
2026-01-06 Craig-Hallum $40 $26 -14 +31.2% $19.81
2025-12-15 Wells Fargo Brandon Couillard Initiated $18 -12.5% $20.57
2025-03-03 H.C. Wainwright Initiated $25 +18.3% $21.13
2024-11-05 BTIG Sung Ji Nam $40 $35 -5 +52.8% $22.90
2024-08-19 BTIG Mark Massaro Initiated $40 +21.2% $33.00
2024-08-16 Craig-Hallum Bill Bonello $32 $40 +8 +21.3% $32.98
2024-08-01 Craig-Hallum Bill Bonello Initiated $32 +60.1% $19.99
2024-04-17 Stephens Mason Carrico $50 $15 -35 +80.9% $8.29
2023-02-06 Goldman Sachs Initiated $29 +78.4% $16.26
2022-04-25 Stephens Initiated $50 +57.6% $31.72

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
3
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CDNA receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-14 C C-
2026-04-30 C- C
2026-02-26 A- C-
2026-01-03 B+ A-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

52 Grade C
Profitability
23
Balance Sheet
96
Earnings Quality
36
Growth
48
Value
38
Momentum
47
Safety
90
Cash Flow
73
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CDNA scores highest in Balance Sheet (96/100) and lowest in Profitability (23/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.93
Safe Zone
Piotroski F-Score
5/9
Beneish M-Score
-3.44
Unlikely Manipulator
Ohlson O-Score
-8.98
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A+
Score: 76.8/100
Trend: Deteriorating
Earnings Quality
OCF/NI: -8.90x
Accruals: -17.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CDNA scores 3.93, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CDNA scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CDNA's score of -3.44 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CDNA's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CDNA receives an estimated rating of A+ (score: 76.8/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-135.04x
PEG
0.88x
P/S
2.71x
P/B
3.53x
P/FCF
14.15x
P/OCF
12.64x
EV/EBITDA
75.95x
EV/Revenue
1.85x
EV/EBIT
-71.32x
EV/FCF
11.73x
Earnings Yield
-0.89%
FCF Yield
7.07%
Shareholder Yield
9.52%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CDNA currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.023
NI / EBT
×
Interest Burden
0.747
EBT / EBIT
×
EBIT Margin
-0.026
EBIT / Rev
×
Asset Turnover
0.913
Rev / Assets
×
Equity Multiplier
1.327
Assets / Equity
=
ROE
-2.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CDNA's ROE of -2.4% is driven by Asset Turnover (0.913), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.02 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$21.63
Median 1Y
$15.21
5th Pctile
$4.37
95th Pctile
$54.16
Ann. Volatility
76.6%
Analyst Target
$27.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
John W. Hanna
President and Chief Executive Officer
$693,269 $5,622,638 $7,179,699
Keith Kennedy Operating
rating Officer and Chief Financial Officer
$587,606 $2,162,552 $3,219,231
Abhishek Jain Financial
ief Financial Officer
$282,100 $1,557,034 $2,637,934
Jessica Meng Commercial
ercial Officer
$485,414 $1,730,053 $2,579,380
Jeffrey Novack Counsel
Counsel and Secretary
$361,923 $648,758 $1,239,552
Nathan Smith Financial
ief Financial Officer
$141,539 $724,200 $967,959

CEO Pay Ratio

26:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $7,179,699
Avg Employee Cost (SGA/emp): $274,782
Employees: 765

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
765
+17.7% YoY
Revenue / Employee
$496,477
Rev: $379,805,000
Profit / Employee
$-27,914
NI: $-21,354,000
SGA / Employee
$274,782
Avg labor cost proxy
R&D / Employee
$93,371
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -4.8% -9.6% -8.2% -13.3% -18.7% -20.0% -17.1% -18.0% -18.7% -20.2% -55.0% -52.9% -47.1% -42.4% 15.4% 17.4% 16.2% 19.0% -6.3% -2.4% -2.40%
ROA -3.4% -6.9% -6.6% -10.6% -14.8% -15.9% -13.8% -14.5% -15.1% -16.3% -37.7% -36.3% -32.3% -29.1% 10.3% 11.6% 10.8% 12.7% -4.7% -1.8% -1.81%
ROIC -12.9% -19.3% -16.9% -27.3% -37.0% -41.9% -34.5% -36.9% -39.5% -44.6% -2.7% -2.6% -2.3% -2.1% 25.5% 29.5% 27.0% 35.7% -15.4% -7.2% -7.16%
ROCE -3.9% -5.8% -6.1% -9.8% -13.3% -15.0% -16.5% -17.7% -18.7% -21.2% -26.9% -25.7% -20.7% -16.0% -14.2% -11.4% -12.2% -9.1% -6.4% -3.3% -3.32%
Gross Margin 67.7% 67.1% 65.9% 66.2% 65.8% 64.3% 64.2% 66.4% 63.2% 63.5% 60.9% 64.0% 69.7% 66.7% 67.5% 66.4% 66.9% 68.7% 66.6% 71.4% 71.43%
Operating Margin -6.4% -11.5% -19.4% -24.0% -26.9% -21.8% -23.2% -31.5% -39.3% -42.8% -1.9% -26.8% -7.9% -12.7% 86.3% -15.8% -12.8% 2.0% -5.4% 1.5% 1.53%
Net Margin -2.6% -15.7% -20.4% -24.7% -26.9% -21.3% -22.2% -30.7% -35.5% -35.0% -1.8% -23.1% -5.0% -8.9% 90.1% -12.2% -9.9% 1.7% -3.8% 2.4% 2.39%
EBITDA Margin -2.6% -7.6% -15.2% -19.5% -22.4% -16.4% -17.7% -25.3% -31.0% -35.4% -30.2% -19.6% -2.6% -6.8% -17.6% -3.6% -6.6% 7.2% 1.4% 6.0% 6.05%
FCF Margin -10.6% -11.3% -13.3% -10.9% -14.4% -17.3% -15.4% -6.8% -4.5% -4.6% -9.9% -15.4% -7.5% 0.4% 9.5% 5.8% 3.5% 10.4% 9.6% 15.8% 15.79%
OCF Margin -4.5% -5.9% -6.5% -2.3% -6.6% -8.9% -7.8% -1.0% 0.1% -0.9% -6.6% -12.5% -5.0% 2.5% 11.4% 7.7% 5.2% 11.9% 11.1% 17.7% 17.67%
ROE 3Y Avg snapshot only -19.37%
ROE 5Y Avg snapshot only -17.50%
ROA 3Y Avg snapshot only -9.97%
ROIC 3Y Avg snapshot only -43.20%
ROIC Economic snapshot only -3.31%
Cash ROA snapshot only 17.65%
Cash ROIC snapshot only 50.11%
CROIC snapshot only 44.78%
NOPAT Margin snapshot only -2.53%
Pretax Margin snapshot only -1.94%
R&D / Revenue snapshot only 18.00%
SGA / Revenue snapshot only 54.58%
SBC / Revenue snapshot only 8.66%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -534.21 -185.20 -78.40 -39.52 -16.48 -12.23 -7.97 -6.07 -5.45 -4.19 -3.33 -2.99 -4.98 -11.26 25.27 17.63 20.53 12.86 -45.10 -112.58 -135.044
P/S Ratio 18.85 12.10 8.11 6.36 3.63 2.86 1.90 1.53 1.48 1.28 2.26 1.99 2.73 5.28 3.73 2.83 3.11 2.18 2.54 2.23 2.707
P/B Ratio 17.21 12.02 5.16 4.21 2.46 1.95 1.42 1.14 1.06 0.88 2.42 2.09 3.10 6.32 3.29 2.59 2.80 2.06 3.18 3.04 3.529
P/FCF -177.56 -107.24 -60.77 -58.53 -25.15 -16.50 -12.32 -22.65 -32.74 -27.59 -22.90 -12.93 -36.34 1352.01 39.49 48.68 89.33 21.06 26.42 14.15 14.149
P/OCF 1646.38 212.41 32.76 36.63 59.88 18.36 22.92 12.64 12.644
EV/EBITDA -4285.82 -496.33 -116.40 -46.51 -15.92 -9.95 -5.82 -3.62 -2.95 -1.57 -5.08 -4.36 -10.15 -34.63 -27.20 -28.52 -28.00 -32.64 -6713.86 75.95 75.949
EV/Revenue 18.03 11.35 7.01 5.30 2.59 1.83 1.11 0.74 0.66 0.42 1.54 1.26 2.05 4.64 3.04 2.16 2.43 1.53 2.12 1.85 1.853
EV/EBIT -395.11 -180.05 -69.86 -34.10 -12.58 -7.93 -4.62 -2.86 -2.33 -1.26 -4.12 -3.47 -7.59 -23.40 -17.78 -16.37 -16.86 -14.97 -39.23 -71.32 -71.317
EV/FCF -169.89 -100.60 -52.50 -48.77 -17.96 -10.57 -7.19 -10.91 -14.57 -9.11 -15.62 -8.18 -27.32 1187.37 32.13 37.15 69.78 14.80 22.10 11.73 11.732
Earnings Yield -0.2% -0.5% -1.3% -2.5% -6.1% -8.2% -12.5% -16.5% -18.3% -23.9% -30.1% -33.5% -20.1% -8.9% 4.0% 5.7% 4.9% 7.8% -2.2% -0.9% -0.89%
FCF Yield -0.6% -0.9% -1.6% -1.7% -4.0% -6.1% -8.1% -4.4% -3.1% -3.6% -4.4% -7.7% -2.8% 0.1% 2.5% 2.1% 1.1% 4.7% 3.8% 7.1% 7.07%
PEG Ratio snapshot only 0.881
Price/Tangible Book snapshot only 3.996
EV/OCF snapshot only 10.484
EV/Gross Profit snapshot only 2.702
Shareholder Yield snapshot only 9.52%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 3.95 3.95 5.61 5.61 5.61 5.61 5.10 5.10 5.10 5.10 4.02 4.02 4.02 4.02 3.94 3.94 3.94 3.94 2.86 2.86 2.862
Quick Ratio 3.80 3.80 5.38 5.38 5.38 5.38 4.85 4.85 4.85 4.85 3.77 3.77 3.77 3.77 3.72 3.72 3.72 3.72 2.56 2.56 2.565
Debt/Equity 0.07 0.07 0.05 0.05 0.05 0.05 0.09 0.09 0.09 0.09 0.13 0.13 0.13 0.13 0.07 0.07 0.07 0.07 0.06 0.06 0.065
Net Debt/Equity -0.74 -0.74 -0.70 -0.70 -0.70 -0.70 -0.59 -0.59 -0.59 -0.59 -0.77 -0.77 -0.77 -0.77 -0.61 -0.61 -0.61 -0.61 -0.52 -0.52 -0.520
Debt/Assets 0.05 0.05 0.04 0.04 0.04 0.04 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.06 0.06 0.06 0.06 0.05 0.05 0.048
Debt/EBITDA -16.97 -2.87 -1.20 -0.61 -0.42 -0.36 -0.64 -0.60 -0.57 -0.49 -0.40 -0.43 -0.57 -0.82 -0.76 -1.08 -0.96 -1.69 -163.99 1.95 1.954
Net Debt/EBITDA 193.63 32.74 18.34 9.31 6.38 5.58 4.15 3.89 3.68 3.19 2.37 2.53 3.35 4.80 6.23 8.85 7.85 13.81 1312.74 -15.64 -15.643
Interest Coverage
Equity Multiplier 1.33 1.33 1.22 1.22 1.22 1.22 1.26 1.26 1.26 1.26 1.79 1.79 1.79 1.79 1.30 1.30 1.30 1.30 1.36 1.36 1.363
Cash Ratio snapshot only 1.972
Cash to Debt snapshot only 9.005
FCF to Debt snapshot only 3.313
Defensive Interval snapshot only 270.9 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.97 1.06 0.63 0.66 0.67 0.68 0.58 0.58 0.56 0.54 0.56 0.54 0.59 0.62 0.70 0.72 0.71 0.75 0.84 0.91 0.913
Inventory Turnover 10.14 11.14 7.16 7.55 7.81 8.07 6.16 6.11 6.02 5.81 5.27 5.27 5.38 5.54 5.63 5.76 5.79 5.98 5.39 5.62 5.617
Receivables Turnover 8.64 9.40 6.28 6.54 6.67 6.75 5.10 5.07 4.91 4.71 4.78 4.69 5.06 5.33 5.77 5.99 5.89 6.19 7.08 7.70 7.699
Payables Turnover 10.72 11.78 8.47 8.93 9.24 9.55 9.64 9.56 9.42 9.10 8.94 8.94 9.12 9.39 10.67 10.91 10.98 11.34 14.10 14.69 14.686
DSO 42 39 58 56 55 54 72 72 74 77 76 78 72 68 63 61 62 59 52 47 47.4 days
DIO 36 33 51 48 47 45 59 60 61 63 69 69 68 66 65 63 63 61 68 65 65.0 days
DPO 34 31 43 41 39 38 38 38 39 40 41 41 40 39 34 33 33 32 26 25 24.9 days
Cash Conversion Cycle 44 41 66 63 62 61 93 94 96 100 105 106 100 96 94 91 92 88 93 88 87.5 days
Fixed Asset Turnover snapshot only 7.407
Operating Cycle snapshot only 112.4 days
Cash Velocity snapshot only 2.330
Capital Intensity snapshot only 1.001
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 69.3% 62.9% 54.2% 39.4% 24.2% 15.5% 8.6% 3.6% -1.8% -6.7% -12.9% -13.9% -4.0% 5.3% 19.1% 25.9% 14.7% 14.5% 13.8% 19.2% 19.17%
Net Income 52.8% 9.8% -63.8% -2.7% -6.8% -3.1% -1.5% -62.7% -21.0% -21.6% -1.5% -1.3% -94.0% -62.2% 1.3% 1.3% 1.3% 1.4% -1.4% -1.1% -1.15%
EPS 59.6% 16.0% -52.9% -2.5% -6.6% -3.1% -1.5% -60.8% -19.7% -20.1% -1.5% -1.4% -1.0% -66.1% 1.2% 1.3% 1.3% 1.4% -1.5% -1.2% -1.15%
FCF -3.0% -3.2% -2.7% -3.1% -69.0% -77.2% -25.3% 35.4% 69.3% 75.1% 44.3% -95.6% -59.6% 1.1% 2.1% 1.5% 1.5% 29.4% 15.5% 2.2% 2.24%
EBITDA 93.5% 45.4% -1.2% -11.2% -47.1% -8.3% -2.4% -85.8% -34.5% -36.0% -38.7% -21.8% 13.0% 47.5% 56.1% 67.0% 50.7% 59.9% 99.7% 1.4% 1.38%
Op. Income 59.9% 30.4% -32.0% -1.7% -4.6% -3.2% -1.6% -72.2% -36.2% -35.8% -1.6% -1.4% -1.0% -60.0% 1.2% 1.2% 1.2% 1.3% -1.8% -1.3% -1.30%
OCF Growth snapshot only 1.72%
Asset Growth snapshot only -15.85%
Equity Growth snapshot only -19.91%
Debt Growth snapshot only -30.62%
Shares Change snapshot only -3.86%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 64.9% 61.4% 57.0% 51.6% 45.5% 40.6% 36.3% 31.8% 27.3% 20.6% 13.4% 7.5% 5.4% 4.3% 4.0% 3.9% 2.7% 4.0% 5.7% 8.9% 8.90%
Revenue 5Y 52.2% 49.9% 48.8% 46.5% 46.3% 46.8% 46.1% 44.5% 40.5% 35.3% 29.6% 25.5% 23.8% 22.2% 21.3% 20.0% 17.9% 16.1% 14.6% 13.3% 13.29%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 75.0% 70.7% 65.9% 58.0% 50.3% 43.0% 36.9% 31.6% 26.7% 19.4% 11.4% 5.2% 3.8% 3.3% 4.0% 4.4% 3.0% 4.9% 6.8% 10.8% 10.75%
Gross Profit 5Y 58.2% 57.4% 59.1% 56.4% 54.2% 53.6% 50.7% 48.9% 44.1% 38.5% 32.6% 27.1% 25.7% 23.5% 22.4% 20.7% 18.4% 16.5% 14.6% 13.7% 13.71%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y -2.1% 21.5% 9.6%
OCF 3Y -76.2%
OCF 5Y 90.3% 2.6% -2.9% 11.1% 4.7% 91.2% 91.18%
Assets 3Y 64.0% 64.0% 63.1% 63.1% 63.1% 63.1% 53.0% 53.0% 53.0% 53.0% 8.2% 8.2% 8.2% 8.2% -4.7% -4.7% -4.7% -4.7% -8.7% -8.7% -8.70%
Assets 5Y 46.0% 46.0% 49.2% 49.2% 49.2% 49.2% 45.4% 45.4% 45.4% 45.4% 29.0% 29.0% 29.0% 29.0% 26.5% 26.5% 26.5% 26.5% 2.3% 2.3% 2.32%
Equity 3Y 69.3% 69.3% 69.3% 69.3% 63.3% 63.3% 63.3% 63.3% -2.0% -2.0% -2.0% -2.0% -6.7% -6.7% -6.7% -6.7% -11.1% -11.1% -11.07%
Book Value 3Y 54.5% 56.2% 56.6% 56.7% 51.1% 51.5% 53.5% 57.9% -4.2% -2.3% -2.0% -2.1% -9.7% -8.0% -7.3% -6.8% -9.7% -10.8% -10.78%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.85 0.87 0.89 0.91 0.93 0.95 0.96 0.97 0.94 0.89 0.81 0.74 0.77 0.75 0.71 0.69 0.73 0.80 0.83 0.82 0.818
Earnings Stability 0.16 0.17 0.44 0.07 0.00 0.00 0.02 0.06 0.07 0.14 0.53 0.60 0.69 0.85 0.02 0.01 0.01 0.00 0.01 0.03 0.025
Margin Stability 0.91 0.90 0.87 0.87 0.89 0.90 0.93 0.93 0.93 0.94 0.93 0.95 0.96 0.97 0.98 0.97 0.99 0.98 0.98 0.97 0.966
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0
Earnings Persistence 0.50 0.96 0.50 0.50 0.50 0.50 0.50 0.50 0.92 0.91 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.20 0.20 0.200
Earnings Smoothness
ROE Trend 0.27 0.15 0.08 0.02 -0.04 -0.03 -0.11 -0.11 -0.10 -0.10 -0.61 -0.55 -0.45 -0.38 0.58 0.59 0.55 0.55 0.23 0.25 0.250
Gross Margin Trend 0.05 0.03 0.01 0.00 -0.00 -0.01 -0.02 -0.02 -0.03 -0.02 -0.03 -0.03 -0.00 0.01 0.03 0.04 0.02 0.02 0.02 0.03 0.033
FCF Margin Trend -0.13 -0.14 -0.17 -0.07 -0.14 -0.16 -0.15 0.01 0.08 0.10 0.05 -0.07 0.02 0.11 0.22 0.17 0.09 0.12 0.10 0.21 0.206
Sustainable Growth Rate 15.4% 17.4% 16.2% 19.0%
Internal Growth Rate 11.5% 13.1% 12.1% 14.5%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.28 0.90 0.63 0.14 0.30 0.38 0.33 0.04 -0.00 0.03 0.10 0.19 0.09 -0.05 0.77 0.48 0.34 0.70 -1.97 -8.90 -8.904
FCF/OCF 2.35 1.91 2.05 4.70 2.19 1.95 1.96 6.98 -50.28 4.87 1.50 1.23 1.49 0.16 0.83 0.75 0.67 0.87 0.87 0.89 0.894
FCF/Net Income snapshot only -7.957
OCF/EBITDA snapshot only 7.244
CapEx/Revenue 6.1% 5.4% 6.8% 8.6% 7.8% 8.4% 7.6% 5.8% 4.6% 3.7% 3.3% 2.9% 2.5% 2.1% 1.9% 1.9% 1.7% 1.5% 1.5% 1.9% 1.88%
CapEx/Depreciation snapshot only 0.373
Accruals Ratio 0.01 -0.01 -0.02 -0.09 -0.10 -0.10 -0.09 -0.14 -0.15 -0.16 -0.34 -0.29 -0.29 -0.31 0.02 0.06 0.07 0.04 -0.14 -0.18 -0.179
Sloan Accruals snapshot only -0.256
Cash Flow Adequacy snapshot only 9.399
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 1.1% 0.0% 96.7% 1.2%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.3% 0.3% 0.6% 4.4% 5.0% 3.4% 1.6% 0.0% 0.0% 4.7% 9.7% 9.1% 9.5% 9.52%
Net Buyback Yield -3.9% -5.7% -7.9% -0.0% -0.0% 0.0% 0.1% 0.3% 0.3% 0.6% 4.4% 5.0% 3.4% 1.6% 0.0% 0.0% 4.7% 9.6% 8.9% 9.2% 9.22%
Total Shareholder Return -3.9% -5.7% -7.9% -0.0% -0.0% 0.0% 0.1% 0.3% 0.3% 0.6% 4.4% 5.0% 3.4% 1.6% 0.0% 0.0% 4.7% 9.6% 8.9% 9.2% 9.22%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.92 0.96 0.96 0.98 0.98 0.99 1.00 1.01 1.01 1.00 1.00 1.00 1.00 1.00 0.99 0.99 0.99 1.00 1.01 1.02 1.023
Interest Burden (EBT/EBIT) 0.84 1.08 1.08 1.06 1.09 1.02 0.99 0.97 0.95 0.91 1.82 1.84 2.03 2.36 -0.87 -1.23 -1.06 -1.66 1.03 0.75 0.747
EBIT Margin -0.05 -0.06 -0.10 -0.16 -0.21 -0.23 -0.24 -0.26 -0.28 -0.33 -0.37 -0.36 -0.27 -0.20 -0.17 -0.13 -0.14 -0.10 -0.05 -0.03 -0.026
Asset Turnover 0.97 1.06 0.63 0.66 0.67 0.68 0.58 0.58 0.56 0.54 0.56 0.54 0.59 0.62 0.70 0.72 0.71 0.75 0.84 0.91 0.913
Equity Multiplier 1.38 1.38 1.26 1.26 1.26 1.26 1.24 1.24 1.24 1.24 1.46 1.46 1.46 1.46 1.50 1.50 1.50 1.50 1.33 1.33 1.327
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.17 $-0.34 $-0.58 $-0.94 $-1.30 $-1.39 $-1.43 $-1.50 $-1.56 $-1.67 $-3.61 $-3.54 $-3.12 $-2.77 $0.85 $1.01 $0.95 $1.13 $-0.42 $-0.15 $-0.15
Book Value/Share $5.32 $5.27 $8.81 $8.79 $8.75 $8.71 $8.05 $8.03 $8.00 $7.95 $4.96 $5.06 $5.01 $4.94 $6.50 $6.85 $6.97 $7.04 $5.93 $5.70 $6.13
Tangible Book/Share $4.01 $3.98 $7.16 $7.14 $7.11 $7.08 $6.55 $6.53 $6.51 $6.47 $3.32 $3.39 $3.36 $3.31 $5.15 $5.43 $5.52 $5.58 $4.51 $4.34 $4.34
Revenue/Share $4.86 $5.24 $5.61 $5.82 $5.91 $5.96 $6.01 $5.96 $5.74 $5.48 $5.32 $5.32 $5.69 $5.91 $5.73 $6.27 $6.28 $6.66 $7.43 $7.77 $8.07
FCF/Share $-0.52 $-0.59 $-0.75 $-0.63 $-0.85 $-1.03 $-0.93 $-0.40 $-0.26 $-0.25 $-0.52 $-0.82 $-0.43 $0.02 $0.54 $0.36 $0.22 $0.69 $0.71 $1.23 $1.27
OCF/Share $-0.22 $-0.31 $-0.37 $-0.13 $-0.39 $-0.53 $-0.47 $-0.06 $0.01 $-0.05 $-0.35 $-0.66 $-0.29 $0.15 $0.65 $0.48 $0.33 $0.79 $0.82 $1.37 $1.43
Cash/Share $4.30 $4.27 $6.59 $6.57 $6.54 $6.52 $5.48 $5.46 $5.44 $5.41 $4.46 $4.55 $4.51 $4.45 $4.48 $4.72 $4.80 $4.85 $3.47 $3.34 $3.66
EBITDA/Share $-0.02 $-0.12 $-0.34 $-0.66 $-0.96 $-1.10 $-1.14 $-1.22 $-1.28 $-1.47 $-1.61 $-1.54 $-1.15 $-0.79 $-0.64 $-0.48 $-0.55 $-0.31 $-0.00 $0.19 $0.19
Debt/Share $0.35 $0.34 $0.40 $0.40 $0.40 $0.40 $0.73 $0.73 $0.72 $0.72 $0.65 $0.66 $0.66 $0.65 $0.49 $0.51 $0.52 $0.53 $0.38 $0.37 $0.37
Net Debt/Share $-3.96 $-3.92 $-6.19 $-6.17 $-6.14 $-6.12 $-4.75 $-4.74 $-4.72 $-4.69 $-3.82 $-3.89 $-3.85 $-3.80 $-3.99 $-4.20 $-4.28 $-4.32 $-3.08 $-2.96 $-2.96
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 3.933
Altman Z-Prime snapshot only 5.474
Piotroski F-Score 4 4 4 4 3 3 2 3 3 1 2 2 4 5 6 6 5 6 4 5 5
Beneish M-Score -1.98 -2.16 -1.95 -2.23 -2.24 -2.16 -2.85 -3.09 -3.10 -3.17 -4.39 -4.14 -4.05 -4.12 -2.21 -2.00 -1.91 -2.11 -3.24 -3.44 -3.437
Ohlson O-Score snapshot only -8.984
ROIC (Greenblatt) snapshot only -4.81%
Net-Net WC snapshot only $2.77
EVA snapshot only $-24981250.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A+
Credit Score 70.74 70.96 70.91 71.80 71.75 72.25 62.68 57.47 58.26 52.10 48.36 48.21 48.28 73.67 93.28 93.45 95.24 89.90 79.13 76.81 76.811
Credit Grade snapshot only 5
Credit Trend snapshot only -16.643
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 72
Sector Credit Rank snapshot only 76

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms